The Phase III Study Data of Stapokibart for Seasonal Allergic Rhinitis Published in Nature Medicine
Press Releases
Keymed Biosciences  
April 6, 2025

The Phase III Study Data of Stapokibart for Seasonal Allergic Rhinitis Published in Nature Medicine

CHENGDU, China, April 5, 2025 /PRNewswire/ -- Keymed Biosciences Inc. (HKEX: 02162) ("Keymed" or the "Company") today announced that the prestigious medical journal Nature Medicine has published the results from

avatar profile Olean Times Herald

Olean Times Herald


Local & Social